Shots: The companies collaborated to launch a digital companion app i.e., Brisa to treat patients with MS. The app will be offered free of charge for users and motivates to […]readmore
Shots: The clinical study evaluates Wise’s Personal Zen app in 35 patients with MS. The company is developing PTD with adaptive, personalized gameplay to address mental health needs in targeted […]readmore
Shots: Medtronic Discovery app will be used to recruit participants, communicate with them, and collect data throughout large-scale clinical studies designed to be conducted remotely. The study enrolls ~5,000 patients […]readmore
Shots: Pear signs a SPAC merger with THMA for pro forma equity value of ~ $1.6B & is expected to provide ~ $400M in gross proceeds include $276M in Thimble […]readmore
Shots: CytoReason reports the initiation of a project with Sanofi by utilizing its cell-centered models and deconvolution techniques to counsel mechanistic insights for each asthma endotype The focus of the […]readmore
Shots: The 18mos. alliance will support two studies that will evaluate clinical tools, include proteomics & digital health for Lupus management in the US The 1st study will evaluate the […]readmore
Shots: The acquisition will expand Walmart’s services to provide access to virtual care including urgent, behavioral, and primary care. The acquisition is expected to close in the coming mos. The […]readmore
Shots: Medtronic launches CareGuidePro, a mobile app and first online portal for patients to navigate their spinal cord stimulation therapy journey. The app is developed in partnership with Higgs Boson […]readmore
Shots: Voluntis enters into a license agreement with Eisai to design & develop DTx for patients and healthcare professionals to support cancer treatment, utilizing the Theraxium technology platform The DTx […]readmore
Shots: Microsoft to acquire all outstanding shares of Nuance for $56.00/ share, making a total deal value of $19.7B in cash with a premium of 23% to Nuance closing price […]readmore